- Finalization of agreement with distribution partner in
Argentina allows access into
initial Latin American markets
- Anade SA is a well-established partner with deep existing
relationships in neurosurgical space
STOCKHOLM, Dec. 10, 2020 /PRNewswire/ -- IRRAS AB, a
commercial-stage medical technology company with a comprehensive
portfolio of innovative products for neurocritical care, today
announced an exclusive distribution agreement with Anade SA, a
well-established distributor of leading neurosurgical medical
devices and technologies through Latin
America.
"We are pleased to partner with Anade SA to expand the
commercial availability of our IRRAflow product line to
physicians and patients throughout multiple markets in Latin America," said Coenraad Tamse, Vice President of International
Sales for IRRAS. "Currently, IRRAflow has received
regulatory clearance in Costa Rica
and Argentina, and regulatory
clearance is being pursued in 5 additional markets. This
partnership allows us to accelerate commercial launches in these
markets with the capable sales professionals of Anade and its
sub-distribution partners identifying and training customers in
each of these new markets."
Miguel Ferro, Vice President of
Anade SA, added, "We are excited to bring an exciting product, such
as IRRAflow, to these initial markets in Latin America. IRRAflow clearly
complements our existing neurosurgery portfolio by providing a next
generation solution for the treatment of intracranial bleeding, and
our team is actively working with leading physicians to plan an
effective product launch."
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP
Monitoring product lines to hospitals worldwide through its direct
sales organization in the United
States and select European countries as well as an
international network of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
USA
Kleanthis G. Xanthopoulos,
Ph.D.
CEO
ir@irras.com
Europe
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on December 10, 2020 at 08:00 (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irras-announces-expansion-of-irraflow-launch-to-latin-america,c3252058